Related Experiment Videos
Opioid antagonist peptides derived from kappa-casein.
1Department of Food Science and Technology, Faculty of Agriculture, Kyoto University, Japan.
The Journal of Dairy Research
|January 1, 1989
Summary
Researchers identified opioid antagonist properties in bovine kappa-casein fragments. These findings reveal potential new therapeutic targets derived from milk proteins.
Area of Science:
- Biochemistry
- Pharmacology
Background:
- Kappa-casein is a major milk protein.
- Opioid receptors play crucial roles in pain and addiction.
Purpose of the Study:
- To investigate opioid antagonist activities within bovine kappa-casein fragments.
- To identify specific peptide sequences with opioid antagonist potential.
Main Methods:
- Chemical synthesis of kappa-casein peptides.
- Enzymatic digestion of kappa-casein.
- Guinea pig ileum assay for opioid antagonist activity testing.
- Reverse-phase High-Performance Liquid Chromatography (HPLC) for peptide isolation.
Main Results:
- Synthetic peptide casoxin A (bovine kappa-casein 35-41) exhibited opioid antagonist activity.
- Synthetic peptide casoxin B (found in bovine and human kappa-casein) also demonstrated opioid antagonist activity.
- Opioid antagonist peptide casoxin C (bovine kappa-casein 25-34) was isolated and showed significant activity.
Conclusions:
- Bovine kappa-casein contains at least three distinct peptide sequences with opioid antagonist properties.
- These identified peptides represent potential therapeutic leads for opioid-related conditions.